Retigabine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N03AX21
CAS registry number (Chemical Abstracts Service)
0150812-12-7
Chemical Formula
C16-H18-F-N3-O2
Molecular Weight
303
Therapeutic Category
Antiepileptic agent (adjunct)
Chemical Names
Carbamic acid, [2-amino-4-[[(4-fluoro-phenyl)metyl]amino]phenyl]-etyl ester (USAN)
Etyl 2-amino-4-[(p-fluorobenzyl)amino]carbanilate (WHO)
Foreign Names
- Retigabinum (Latin)
- Retigabin (German)
- Rétigabine (French)
- Retigabina (Spanish)
Generic Names
- Ezogabine (OS: USAN)
- Retigabine (OS: BAN)
- AWD21-360 (IS)
- D-23129 (IS)
- GKE-841 (IS)
- GW-582892X (IS)
- UNII-12G01I6BBU (IS)
- WAY-143841 (IS)
Brand Names
- Potiga
GlaxoSmithKline, United States - Trobalt
Glaxo Group, Austria; Glaxo Group, Hungary; Glaxo Group, Lithuania; Glaxo Group, Poland; Glaxo Group, Romania; Glaxo Group, Slovenia; Glaxo Group, Slovakia; Glaxo Wellcome, Portugal; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Georgia; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Italy; GlaxoSmithKline, Latvia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden; GlaxoSmithKline Laboratoire Pharmaceutique, France; GlaxoSmithKline UK, United Kingdom; GSK, Belgium; Wellcome Limited, Bosnia & Herzegowina
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
